N-of-One Qiagen Acquires N-of-One to Add Molecular Decision Support With the acquisition, Qiagen will integrate N-of-One’s MarkerMine database into its core technology to help customers design new, targeted therapies. Sunquest to Integrate Mitogen LIS With N-of-One Oncology Technology Sunquest and N-of-One are aiming to help pathologists create actionable, patient-specific genetic reports from NGS panels. Agena Bioscience Partners With N-of-One on MassArray Data Interpretation N-of-One will help Agena interpret cancer genomic data generated by its MassArray system as part of a recently launched reporting network. Philips Inks Precision Oncology Agreements With WMCHealth, N-of-One One deal will see Philips' solution used to improve cancer patient outcomes while the other will beef up its ability to interpret data from oncology tests. N-of-One to Interpret Med Fusion's HemeSeq Tests N-of-One will interpret data from HemeSeq profiles for acute myeloid leukemia, chronic lymphocytic leukemia, diffuse large B-cell lymphoma, and other cancers. Nov 3, 2016 Inivata, N-of-One Partner to Provide Interpretation, Clinical Trial Matching for Cancer Patients Jul 21, 2016 N-of-One Raises $7M in Series B Financing Round Apr 12, 2016 Admera Taps N-of-One for Clinical Interpretation of OncoGxOne Oncology Panel Apr 5, 2016 N-of-One Signs Clinical Interpretation Service Deal with Macrogen Nov 17, 2015 WuXi Nextcode Taps N-of-One to Provide Clinical, Scientific Backing for Cancer Interpretation Results Oct 8, 2015 N-of-One Launches PrecisionInsights to Offer Targeted, Lower-Cost Tumor Interpretation Premium Aug 18, 2015 N-of-One to Provide Interpretation Services for Spectrum's Tumor Panel Aug 5, 2015 N-of-One, GenomiCare Partner on Interpreting NGS Tests in China Jul 22, 2015 CompanionDx Taps N-of-One for NGS Clinical Interpretation May 7, 2015 N-of-One Inks Clinical Interpretation Service Deal with Affymetrix Apr 7, 2015 N-of-One to Provide Clinical Interpretation Services for New England VA Oncology Program Mar 17, 2015 Cartagenia, N-of-One Combine Analysis, Interpretation Products Feb 18, 2015 N-of-One Joins Oracle Partner Program Dec 2, 2014 N-of-One Inks Deal With NeoGenomics to Interpret Cancer Dx Tests Nov 18, 2014 N-of-One to Support Oncology Testing at BloodCenter of Wisconsin Oct 28, 2014 Intermountain to Use N-of-One's Clinical Interpretation Service for Oncology Jul 3, 2014 German Dx Firm Taps N-of-One to Provide Clinical Interpretation for NGS Testing Premium May 21, 2014 N-of-One Inks Mayo Clinic MDx Alliance May 19, 2014 N-of-One to Provide Decision Support for Guardant360 Cell-Free DNA Test May 15, 2014 N-of-One to Provide Interpretation Services for OncoDNA NGS Tests Load More Breaking News Pediatric Medulloblastoma Subgroups May Benefit from Lower-Dose Radiation Therapy Space Radiation Shows Limited Effects on Mammalian Sperm DNA, Fertility Bluestar Genomics Sues Former Consultant, Ludwig Institute for Cancer Research Over IP Ownership New Products Posted to GenomeWeb: 10x Genomics, Swift Biosciences, Agilent Technologies, More In Brief This Week: Quantum-Si, TGen, Yale, and More People in the News: New Appointments at Invitae, PGDx, Oxford Nanopore, PacBio, More The Scan Fertility Fraud Found Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today. Ties Between Vigorous Exercise, ALS in Genetically At-Risk People Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports. Test Warning The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK. Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.